Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. / Brunner HI;Ruperto N;Zuber Z;Keane C;Harari O;Kenwright A;Lu P;Cuttica R;Keltsev V;Xavier RM;Calvo I;Nikishina I;Rubio-Pérez N;Alexeeva E;Chasnyk V;Horneff G;Opoka-Winiarska V;Quartier P;Silva CA;Silverman E;Spindler A;Baildam E;Gámir ML;Martin A;Rietschel C;Siri D;Smolewska E;Lovell D;Martini A;De Benedetti F;for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - CD-ROM. - (2014), pp. 1110-1117.